BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2141051)

  • 1. [Chemotherapy with fluoropyrimidines for MOPC-104E plasmacytoma transplanted in mice with CCl4 induced chronic liver dysfunction].
    Tsubono M; Nio Y; Imai S; Shiraishi T; Morimoto H; Tseng CC; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1990 Mar; 25(3):640-7. PubMed ID: 2141051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low uracil concentration in the liver might be responsible for the decreased antineoplastic activity of fluoropyrimidines in mice with CCl4-induced chronic liver dysfunction.
    Tsubono M; Nio Y; Imai S; Shiraishi T; Morimoto H; Tseng CC; Kawabata K; Fukumoto M; Tobe T
    Oncology; 1991; 48(3):246-52. PubMed ID: 2023705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of in vivo antitumor activities of fluorinated pyrimidines to thymidylate synthase activity and intratumoral concentrations of 5-fluorouracil and uracil.
    Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Kawabata K; Imai S; Tobe T
    Anticancer Res; 1991; 11(2):607-12. PubMed ID: 2064315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of fluoropyrimidine, drugs of tegafur and UFT on transplanted tumor in liver-damaged mice].
    Aoike A; Hosokawa T; Koyama K; Rokutan K; Nishi Y; Yoshida A; Nakamura K; Kawai K
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2899-905. PubMed ID: 3140731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5'-deoxy-5-fluorouridine.
    Ooi A; Ohkubo T; Higashigawa M; Kawasaki H; Kakito H; Kagawa Y; Kojima M; Sakurai M
    Biol Pharm Bull; 2001 Nov; 24(11):1329-31. PubMed ID: 11725974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-tumor effect of fluoropyrimidines on human tumor cell lines transplanted in nude mice with CCl4-induced liver dysfunction].
    Nio Y; Imai S; Shiraishi T; Ohgaki K; Tobe T
    Nihon Geka Gakkai Zasshi; 1989 Apr; 90(4):538-45. PubMed ID: 2503704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice.
    Yonekura K; Basaki Y; Chikahisa L; Okabe S; Hashimoto A; Miyadera K; Wierzba K; Yamada Y
    Clin Cancer Res; 1999 Aug; 5(8):2185-91. PubMed ID: 10473104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemosensitivity of head and neck squamous cell carcinomas using subrenal capsule assay--comparative assay of 5-FU, FT, UFT, and HCFU and immunohistochemical study].
    Nakashima T; Miyagi M; Kusumoto T
    Nihon Jibiinkoka Gakkai Kaiho; 1992 Jan; 95(1):95-103. PubMed ID: 1545316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Controlled Trial of Adjuvant Chemotherapy with Fluoropyrimidines
    Moon JH; Fujiwara Y; Hirao M; Imamura H; Kimura Y; Fujitani K; Fujita J; Tamura S; Takiguchi S; Yano M; Mori M; Doki Y
    Anticancer Res; 2017 Jun; 37(6):3061-3067. PubMed ID: 28551645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative studies on the antitumor activity of the fluorinated pyrimidines 5'-DFUR, tegafur, UFT and FUra on various murine tumors].
    Miwa M; Eda H; Fukuda H; Fujimoto K; Ishitsuka H
    Gan To Kagaku Ryoho; 1988 May; 15(5):1755-63. PubMed ID: 2967051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity test for 5-fluorouracil and its analogues, 1-(2-tetrahydrofuryl)-5-fluorouracil, uracil/1-(2-tetrahydrofuryl)-5-fluorouracil (4:1) and 1-hexylcarbamoyl-5-fluorouracil, using the subrenal capsule assay.
    Anai H; Maehara Y; Kusumoto H; Kusumoto T; Sugimachi K
    Oncology; 1988; 45(3):144-7. PubMed ID: 3130595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of calmodulin antagonists (W-5 and W-7) on antitumor activity of Tegafur and UFT (Tegafur plus uracil)].
    Kikuchi Y; Oomori K; Iwano I; Kizawa I; Miyauchi M; Kita T; Kato K
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):422-8. PubMed ID: 3131462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface.
    Nio Y; Hirahara N; Minari Y; Iguchi C; Yamasawa K; Toga T; Tamura K
    Anticancer Res; 2000; 20(5A):3293-9. PubMed ID: 11062756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UFT is more antineoplastic against gastric carcinoma than 5-fluorouracil, 1-(2-tetrahydrofuryl)-5-fluorouracil and 1-hexylcarbamoyl-5-fluorouracil.
    Maehara Y; Kusumoto T; Kusumoto H; Anai H; Sugimachi K
    Chemotherapy; 1988; 34(6):484-9. PubMed ID: 3149571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of fluoropyrimidines].
    Fujita H
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2307-15. PubMed ID: 6437341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur.
    Watanabe M; Nishida O; Kunii Y; Kodaira S; Takahashi T; Tominaga T; Hojyo K; Kato T; Niimoto M; Kunitomo K; Isomoto H; Ohashi Y; Yasutomi M
    Int J Clin Oncol; 2004 Apr; 9(2):98-106. PubMed ID: 15108041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of pharmacokinetics of 5-FU and alpha-fluoro-beta-alanine, a metabolite of 5-FU, in plasma after administration of UFT, tegafur, 5-FU or doxifluridine to rats].
    Kuwata K; Nagayama S; Hirakawa Y; Matsushima E; Kawaguchi Y
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):885-90. PubMed ID: 10897216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of derivatives of Ara-C, 5-fluorouracil and nitrosourea against intracerebral implanted L1210 leukemia].
    Kato T; Ota K
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):502-5. PubMed ID: 2949703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [5-FU concentration in blood and tissue of patients with renal cell carcinoma after administration of UFT].
    Masuda F; Suzuki M; Ohnishi T; Nakada J; Mori Y; Iizuka N; Machida T
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):320-4. PubMed ID: 3918507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitumor effect of UFT on human ovarian cancer grafted to nude mice and 5-FU concentration in tumor and normal tissues].
    Yoshiya N; Adachi S; Misawa Y; Ishida M; Yuzawa H; Kanazawa K; Takeuchi S
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):285-9. PubMed ID: 3124768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.